Insider Transactions in Q3 2025 at Supernus Pharmaceuticals, Inc. (SUPN)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 14
2025
|
Bethany Sensenig Director |
SELL
Open market or private sale
|
Direct |
5,369
-100.0%
|
$225,498
$42.25 P/Share
|
|
Aug 14
2025
|
Frederick M. Hudson Director |
SELL
Open market or private sale
|
Direct |
7,457
-13.87%
|
$313,194
$42.26 P/Share
|
|
Aug 06
2025
|
Jack A. Khattar President, CEO |
SELL
Open market or private sale
|
Direct |
140,000
-4.23%
|
$5,740,000
$41.79 P/Share
|
|
Aug 06
2025
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,250
+5.74%
|
$3,421,250
$17.09 P/Share
|